FDA device shortage update includes bloodlines, biopsy needles and more (opens in new tab)

The FDA has updated its lists of device shortages and discontinued devices. The agency says a shortage of bloodlines used in dialysis has ended, but extended the estimated shortage duration for stereotactic breast biopsy needles, endoscopic vessel harvesting systems and oxygenator devices intended for extracorporeal circulation. Those device shortages are now expected to last through… The post appeared first on .